| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 70 |
| 1 | ASPIRIN | 32 |
| 2 | ASPIRIN 325 MG | 32 |
| 3 | ASPIRIN 81 MG | 32 |
| 4 | FUROSEMIDE | 27 |
| 5 | METOPROLOL | 17 |
| 6 | METOPROLOL TARTRATE | 17 |
| 7 | ROSUVASTATIN | 17 |
| 8 | ATORVASTATIN CALCIUM | 16 |
| 9 | OMEPRAZOLE MAGNESIUM | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PREGABLIN | 1 | 0.0152 |
| 1 | OCTOCRYLENE, AVOBENZONE | 1 | 0.0022 |
| 2 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0016 |
| 3 | PENTOXIFYLLINE | 6 | 0.0014 |
| 4 | CARBOPROST TROMETHAMINE | 1 | 0.0014 |
| 5 | ESTRADIOL ACETATE | 1 | 0.0013 |
| 6 | PRAMOXINE HYDROCHLORIDE HYDROCORTISONE ACETATE | 1 | 0.0012 |
| 7 | DISOPYRAMIDE PHOSPHATE | 1 | 0.0012 |
| 8 | SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE | 1 | 0.0010 |
| 9 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 46 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 32 |
| 2 | Loop Diuretic [EPC] | 30 |
| 3 | Corticosteroid [EPC] | 24 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 23 |
| 5 | beta-Adrenergic Blocker [EPC] | 20 |
| 6 | Vitamin C [EPC] | 16 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 15 |
| 8 | PCSK9 Inhibitor [EPC] | 15 |
| 9 | Vitamin B12 [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Blood Viscosity Reducer [EPC] | 6 | 0.0014 |
| 2 | PCSK9 Inhibitor [EPC] | 15 | 0.0006 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 4 | Anti-anginal [EPC] | 5 | 0.0005 |
| 5 | Vitamin D2 Analog [EPC] | 3 | 0.0004 |
| 6 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 7 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 5 | 0.0004 |
| 8 | Oxytocic [EPC] | 1 | 0.0003 |
| 9 | Plasma Volume Expander [EPC] | 1 | 0.0003 |